Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Supreme Court Gets Nudge On Bayh-Dole Case; Denies HRT Petition; Will Review Infringement “State Of Mind”

Executive Summary

The Solicitor General has urged the Supreme Court to take up a case questioning whether an inventor can eliminate a university’s rights to federally funded research by making an agreement with a third party.

You may also be interested in...

Supreme Court Limits Universities' Rights Under Bayh-Dole, Leaves Contract Questions

In a 7-2 decision, the court says the statute does not give contractors the title to federally funded inventions.

University Patent Rights Could Rely More On Contracts Than Bayh-Dole, Supreme Court Suggests

In oral arguments in Stanford v. Roche, justices question why inventors cannot directly assign their inventions; government is concerned universities could eliminate its share of royalties.

Universities Want Pharma Deals That Offer A Package Of Opportunities

Rather than one-off collaborations, academia wants tie-ups that provide deeper relationships with such things as sponsored research, clinical trials and future deals.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts